Previous studies have shown that Tirzepatide can improve insulin sensitivity and maintain glucose homeostasis by activating GLP-1 and GIP receptors, thereby indirectly alleviating diabetes-induced hyperglycemia and subsequent renal injury (Samms et al., 2021). This evidence concerns the gene GLP1R and diabetes mellitus.